The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...

Basic research may seem far removed from everyday technology, yet it often provides the spark for major industrial shifts.

SMART researchers discover novel phage DNA modifications that offer new hope against antibiotic-resistant superbugsA groundbreaking discovery reveals a unique way phages modify their DNA with ...

Through a $650,000 USDA Grant Yi Li will study the unintended consequences of multiplex genome editing and how many ...

Given the success of the Research Topic ‘Diversity and Molecular Diagnostics of Fungi and Oomycetes in Plants’ Volume I and the rapidly evolving subject ...

In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn ...

ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions ('Dyadic'), a global biotechnology ...

ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered ...

ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for diverse ...

Phase 1 data showed CRISPR’s one-time treatment, CTX310, produced sharp, dose-dependent reductions in triglycerides and LDL cholesterol with a strong safety profile. ・The company plans to advance the ...

Life sciences revolve around many living forms such as humans, plants, animals, and microorganisms. The discoveries made ...

Pioneering CRISPR trial shows single infusion permanently lowers bad cholesterol by 50% in patients who don't respond to medication.